Donepezil Completed Phase 1 Trials for Alzheimer's Disease (AD) / Memory Disturbances Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02051335Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults